MannKind to Present at Jefferies 2013 Global Healthcare Conference

MannKind to Present at Jefferies 2013 Global Healthcare Conference

VALENCIA, Calif.--(BUSINESS WIRE)-- MannKind Corporation (NAS: MNKD) , focused on discovering, developing and commercializing treatments for diabetes, announced today that it will present at the Jefferies 2013 Global Healthcare Conference on Wednesday, June 5, 2013 at 11:00 a.m. (ET) in New York.

Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at

About MannKind Corporation

MannKind Corporation (NAS: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. Its lead product candidate, AFREZZA®, is in late stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia.

MannKind maintains a website at to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.

MannKind Corporation
Matthew J. Pfeffer
Corporate Vice President and
Chief Financial Officer

KEYWORDS:   United States  North America  California  New York


The article MannKind to Present at Jefferies 2013 Global Healthcare Conference originally appeared on

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Can't get enough business news?

Sign up for Finance Report by AOL and get everything from retailer news to the latest IPOs delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.